Video Modules

Share

Program Content

Activities

  • LS-SCLC Management
    Management of Limited-Stage SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2020

    Expires: November 29, 2021

  • IO Rationale for ES-SCLC
    Rationale for Using Immunotherapy in the Treatment of ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • First-line IO for ES-SCLC
    Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • Case: Frontline ES-SCLC
    Case Discussion: Newly Diagnosed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2020

    Expires: December 08, 2021

  • Relapsed ES-SCLC
    Overview of Therapeutic Options for Relapsed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2020

    Expires: November 30, 2021

  • Case: Relapsed ES-SCLC
    Case Discussion: Relapsed ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 05, 2021

    Expires: February 04, 2022

  • Case: Managing irAEs
    Case Discussion: Management of Immune-Related AEs
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 05, 2021

    Expires: February 04, 2022

  • Radiation for ES-SCLC
    Role of Radiation Therapy in the Management of ES-SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

  • Biomarkers for IO in SCLC
    Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 01, 2021

    Expires: January 31, 2022

  • IO Trials in SCLC
    Key Clinical Trials of Immunotherapy in SCLC
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

Faculty

cover img faculity

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Mark A. Socinski, MD

Director, Lung Cancer Section of the Division of Hematology/Oncology
Co-Director, UPMC Center for Excellence in Lung Cancer
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh Cancer Institute
University of Pittsburgh
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

AstraZeneca

Merck Sharp & Dohme Corp.